Chiome Bioscience Inc.
Loading...
Key Metrics
Market Cap
N/A
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
780.8M
Net Income
-1.0B
Gross Margin
N/A
Op. Margin
-132.0%
Net Margin
-130.7%
ROE
-53.2%
ROA
-41.3%
D/E
0.29
Dividend Yield
N/A
EPS
-17.54
Current Ratio
4.74
Price History
Company Info
| Industry | PHARMACEUTICAL |
| Market Segment | Growth |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2024 |
Peers
GNI Group Ltd.
2160
--
P/E: --
Kyowa Kirin Co.,Ltd.
4151
--
P/E: --
--
P/E: --
Astellas Pharma Inc.
4503
--
P/E: --
--
P/E: --
Shionogi & Co.,Ltd.
4507
--
P/E: --
--
P/E: --
--
P/E: --
Financial Statements
Loading financials...
Open Advanced Charts
Full charting with technical indicators, candlestick, and more.
| Ticker | 4583 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |